Hu5F9-G4
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Hu5F9-G4, covering 2019-02-05 to 2022-02-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia [Phase 1]